Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  N-methylformamide
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 26 for your search:
Start Over
Phase I/II Chemotherapy with N-MF in Patients with Metastatic Colorectal Adenocarcinoma
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: MSKCC-83124A, NCI-T83-1418C, T83-1418
Phase I/II Chemotherapy with N-Methylformamide in Children with Drug-Resistant Malignant Solid Tumors and Leukemia
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: under 18
Sponsor: NCI
Protocol IDs: SJCRH-NMF-I/II, NCI-T83-1154D, T83-1154
Phase I/II Study of Chemotherapy with N-Methylformamide in Patients with Chronic Myelogenous Leukemia (Summary Last Modified 05/88)
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: ICC-86H3, NCI-T85-0216D, T85-0216
Phase II Chemotherapy with N-Methylformamide for Nonresectable Squamous Cell Carcinoma of the Head and Neck
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: UMCT-1583, NCI-T83-1262C, T83-1262
Phase II Chemotherapy with N-MF for Advanced or Recurrent Adenocarcinoma of the Colon or Rectum
Phase: Phase II
Type: Treatment
Status: Completed
Age: 15 and over
Sponsor: NCI
Protocol IDs: UMCC-8313, NCI-T83-1076W, T83-1076
Phase II Chemotherapy with N-Methylformamide for Stage III/IV Renal Cell Carcinoma
Phase: Phase II
Type: Treatment
Status: Completed
Age: over 15
Sponsor: NCI
Protocol IDs: UMCC-8308, NCI-T83-1081W, T83-1081
Phase II Pilot Chemotherapy with N-MF for Advanced Inoperable Renal Cell Carcinoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: MSKCC-8376A, NCI-T83-1151C, T83-1151
Phase II Master Protocol for Single-Agent Chemotherapy for Refractory Small Cell Bronchogenic Carcinoma --- Spirogermanium vs N-Methylformamide
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-4583
Phase II Master Protocol for Single-Agent Chemotherapy for Advanced non-Small Cell Lung Cancer --- 4-Demethoxydaunorubicin
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-3583
Phase II Chemotherapy with N-MF for Advanced Lung Cancer
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: UMCT-2683, NCI-T83-1308C, T83-1308
Phase II Chemotherapy with N-Methylformamide for Malignant Glioma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: CAN-NCIC-IND13, NCI-T84-0441W, T84-0441, IND13
Phase II Chemotherapy with N-MF for Metastatic Malignant Melanoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: CAN-NCIC-IND14, NCI-T84-0442W, T84-0442, IND14
Phase II Chemotherapy with N-MF for Advanced or Metastatic Unresectable Colorectal Carcinoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: CAN-NCIC-IND8, NCI-T84-0440W, T84-0440, IND8
Phase II Chemotherapy with N-MF in Patients with Advanced Malignant Melanoma
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-8489, NCI-T84-0397C, T84-0397
Phase II Master Protocol Chemotherapy for Nonresectable, Advanced, or Recurrent Carcinoma of the Breast --- N-MF
Phase: Phase II
Type: Treatment
Status: Closed
Age: over 15
Sponsor: NCI
Protocol IDs: CLB-8441, CALGB-8441
Phase II Master Protocol Evaluation of Single-agent or Combination Chemotherapy for Advanced Colorectal Carcinoma --- N-MF
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: ICC-85I1, NCI-T84-0544D, T84-0544
Phase II Master Protocol Evaluation of Single-agent or Combination Chemotherapy for Advanced non-Small Cell Lung Cancer --- N-MF
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: ICC-85L1, NCI-T84-0542D
Phase II Master Protocol for Advanced, Recurrent Gynecologic Malignancies: N-Methylformamide
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: GOG-26V
Phase II Master Protocol for Ovarian Cancer of Coelomic Epithelial Origin --- Menogaril (Summary Last Modified 04/88)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: EST-1885
Phase II Study of Chemotherapy with N-MF in Patients with Advanced Squamous Cancer of the Uterine Cervix (Summary Last Modified 07/88)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: EST-4886
Phase I Study of Oral N-Methylformamide (NSC-3051)
Phase: Phase I
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: RWGH-8342253, NCI-T83-1056W
Phase I Study of N-Methylformamide (N-MF) (NSC-3051) in Patients with Advanced Cancer
Phase: Phase I
Type: Treatment
Status: Closed
Age: 20 to 75
Sponsor:
Protocol IDs: NCI-W82-0925, W82-0925
Phase I Study of N-Methylformamide
Phase: Phase I
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NCI-W82-1366, UMCC-8227
Phase I Study of Oral N-MF in Patients with Advanced Cancer
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 to 75
Sponsor: NCI
Protocol IDs: JHOC-85091603, NCI-T85-0238W, T85-0238
Phase I Radiosensitization with N-MF plus Radiotherapy in Patients with Advanced Cancer Refractory or Poorly Responsive to Conventional Therapy (Summary Last Modified 05/88)
Phase: Phase I
Type: Treatment
Status: Completed
Age: 16 and over
Sponsor: NCI
Protocol IDs: RIH-871, NCI-T86-0300O, T86-0300
Start Over